155 related articles for article (PubMed ID: 36804217)
21. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
22. Severe sepsis in hematopoietic stem cell transplant recipients*.
Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
[TBL] [Abstract][Full Text] [Related]
23. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan.
Chiu HF; Chung MC; Chung CJ; Yu TM; Shu KH; Wu MJ
Transplant Proc; 2016 Apr; 48(3):918-20. PubMed ID: 27234767
[TBL] [Abstract][Full Text] [Related]
25. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
[TBL] [Abstract][Full Text] [Related]
26. Donor-derived solid malignancies after hematopoietic stem cell transplantation.
Hu YX; Cui Q; Liang B; Huang H
Onkologie; 2010; 33(4):195-200. PubMed ID: 20389147
[TBL] [Abstract][Full Text] [Related]
27. Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities.
Adachi Y; Ukai S; Sagou K; Fukushima N; Ozeki K; Kohno A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1455-1462. PubMed ID: 29476952
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis.
Stiff PJ; Leinonen M; Kullenberg T; Rudebeck M; de Chateau M; Spielberger R
Biol Blood Marrow Transplant; 2016 Jan; 22(1):164-9. PubMed ID: 26303102
[TBL] [Abstract][Full Text] [Related]
29. Metabolic Disease Incidence After Allogeneic Stem Cell Transplantation: A Nationwide Korean Case-Control Study.
Ha J; Park SH; Park SS; Han S
J Clin Endocrinol Metab; 2022 Mar; 107(4):943-952. PubMed ID: 34905058
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Aladağ E; Demiroğlu H; Büyükaşık Y; Göker H
Turk J Haematol; 2021 Jun; 38(2):138-144. PubMed ID: 32539316
[TBL] [Abstract][Full Text] [Related]
31. [Subsequent malignancies after long-term follow-up of pediatric hematopoietic stem cell transplantation].
Sisinni L; Gich I; Torrent M; Badell I
An Pediatr (Engl Ed); 2019 Mar; 90(3):157-164. PubMed ID: 30195711
[TBL] [Abstract][Full Text] [Related]
32. One-year mortality of hematopoietic stem cell recipients admitted to an intensive care unit in a dedicated Brazilian cancer center: a retrospective cohort study.
Archanjo LVF; Caruso P; Nassar Junior AP
Sao Paulo Med J; 2022; 141(2):107-113. PubMed ID: 35920534
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
[TBL] [Abstract][Full Text] [Related]
34. Changes in tuberculosis risk after transplantation in the setting of decreased community tuberculosis incidence: a national population-based study, 2008-2020.
Hyun J; Lee M; Jung I; Kim E; Hahn SM; Kim YR; Lim S; Ihn K; Kim MY; Ahn JG; Yeom JS; Jeong SJ; Kang JM
Ann Clin Microbiol Antimicrob; 2024 Jan; 23(1):1. PubMed ID: 38172897
[TBL] [Abstract][Full Text] [Related]
35. Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.
Arora M; Sun CL; Ness KK; Teh JB; Wu J; Francisco L; Armenian SH; Schad A; Namdar G; Bosworth A; Kuo L; Weisdorf DJ; Forman SJ; Bhatia S
JAMA Oncol; 2016 Oct; 2(10):1277-1286. PubMed ID: 27254472
[TBL] [Abstract][Full Text] [Related]
36. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.
Adhikari J; Sharma P; Bhatt VR
Future Oncol; 2015; 11(23):3175-85. PubMed ID: 26551415
[TBL] [Abstract][Full Text] [Related]
37. Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population.
Barth D; Singleton M; Monohan G; McClune B; Adams V
Cell Transplant; 2022; 31():9636897221080385. PubMed ID: 35225031
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
39. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning.
Cima LN; Martin SC; Lambrescu IM; Stejereanu L; Zaharia C; Colita A; Fica S
J Pediatr Endocrinol Metab; 2018 Aug; 31(8):869-878. PubMed ID: 29935114
[TBL] [Abstract][Full Text] [Related]
40. Outcome and late effects among acute myeloid leukemia survivors: a nationwide population-based study.
Chang KH; Hwang WL; Muo CH; Hsu CY; Teng CJ
Support Care Cancer; 2016 Dec; 24(12):4993-5000. PubMed ID: 27502072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
